TXA (Tranexamic Acid) Risk Evaluation in Combat Casualties (TRECC)

BACKGROUND: The use of tranexamic acid (TXA) has become increasingly prevalent for hemorrhage prevention in military trauma patients due to its known survival benefits. There is concern of increased venous thromboembolism (VTE) subsequent to receiving TXA. The purpose of this retrospective study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Adair, Kathleen E, Patrick, Joshua D, Kliber, Eric J, Peterson, Matthew N, Holland, Seth R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996783/
https://www.ncbi.nlm.nih.gov/pubmed/32072015
http://dx.doi.org/10.1136/tsaco-2019-000353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996783/
https://www.ncbi.nlm.nih.gov/pubmed/32072015
http://dx.doi.org/10.1136/tsaco-2019-000353

Ejemplares similares